Presentation EuroPCR 2024 Methodological Insight: REC-CAGEFREE II Trial Presenter: Robert Byrne May 14, 2024
News Daily News Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift Yael L. Maxwell May 03, 2024
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Conference News ACC 2024 ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI Yael L. Maxwell April 07, 2024
News Conference News ACC 2024 Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI Michael O'Riordan April 07, 2024
News Conference News ACC 2024 Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI Yael L. Maxwell April 06, 2024
News Conference News ACC 2024 Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT Todd Neale March 27, 2024
News Daily News Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI Michael O'Riordan March 26, 2024
News Daily News Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA Michael O'Riordan March 14, 2024
News Conference News CRT 2024 Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis L.A. McKeown March 09, 2024
News Daily News Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial Todd Neale March 04, 2024
News Daily News AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis Todd Neale February 14, 2024
News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024
News Daily News Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI Todd Neale January 16, 2024
News Daily News No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm Yael L. Maxwell January 10, 2024
News Daily News TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable Michael O'Riordan January 09, 2024
News Daily News Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2 Michael O'Riordan January 03, 2024
News Daily News Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial Michael O'Riordan December 27, 2023